 |
PDBsum entry 5o6t
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
A general strategy for discovery of inhibitors and activators of ring and u-Box e3 ligases with ubiquitin variants.
|
 |
|
Authors
|
 |
M.Gabrielsen,
L.Buetow,
M.A.Nakasone,
S.F.Ahmed,
G.J.Sibbet,
B.O.Smith,
W.Zhang,
S.S.Sidhu,
D.T.Huang.
|
 |
|
Ref.
|
 |
Mol Cell, 2017,
68,
456.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
RING and U-box E3 ubiquitin ligases regulate diverse eukaryotic processes and
have been implicated in numerous diseases, but targeting these enzymes remains a
major challenge. We report the development of three ubiquitin variants (UbVs),
each binding selectively to the RING or U-box domain of a distinct E3 ligase:
monomeric UBE4B, phosphorylated active CBL, or dimeric XIAP. Structural and
biochemical analyses revealed that UbVs specifically inhibited the activity of
UBE4B or phosphorylated CBL by blocking the E2∼Ub binding site. Surprisingly,
the UbV selective for dimeric XIAP formed a dimer to stimulate E3 activity by
stabilizing the closed E2∼Ub conformation. We further verified the inhibitory
and stimulatory functions of UbVs in cells. Our work provides a general strategy
to inhibit or activate RING/U-box E3 ligases and provides a resource for the
research community to modulate these enzymes.
|
 |
|
|
|
|
 |